Statement Of Support By The PAP Foundation, Inc. For FDA Approval Of GM-CSF Treatment For aPAP
The PAP Foundation finds compelling evidence of efficacy of inhaled GM-CSF treatment for aPAP patients through review of recently published and publicly available data in conjunction with learnings from prolonged “off-label” use within the PAP Foundation patient community, which is in dire need of an effective therapy to treat this[…]
Read more